Oman vs Tunisia: HIV-positive TB patients on ART (antiretroviral therapy)
Oman
100.0%
in 2024
Tunisia
100.0%
in 2023
Oman rank
1st
Tunisia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Oman
- Tunisia
How they compare
Oman currently reports 100.0% against 100.0% in Tunisia, a difference of 0.0%.
Across all 19 years both countries report, Tunisia has been ahead every year.
Oman ranks 1st and Tunisia ranks 1st of 144 countries.
Tunisia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Oman | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 96.8% | 100.0% | 3.2% | Tunisia |
| 2020s | 89.2% | 100.0% | 10.8% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Oman or Tunisia?
- Oman, at 100.0% against 100.0% in Tunisia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Oman and Tunisia?
- 0.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Tunisia?
- 19 years are reported by both, from 2003 to 2023.
- How do Oman and Tunisia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Oman ranks 1st and Tunisia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.